Inhibition of aldosterone production by adrenomedullin, a hypotensive peptide, in the rat.
Recently, we conducted in vitro studies and reported that adrenomedullin, a novel hypotensive peptide, inhibits aldosterone secretion by dispersed rat adrenal zona glomerulosa cells. To assess the physiological role of this inhibitory effect, we investigated the effect of adrenomedullin on aldosterone production in vivo. Male Sprague-Dawley rats were fed a normal sodium diet before the experiments. To begin the experimental procedure, we stimulated aldosterone production with a sodium-deficient diet or bilateral nephrectomy. After 3 days of sodium depletion or immediately after nephrectomy, we injected synthetic human adrenomedullin (2.5 nmol/kg SC) and repeated the injection three times at 6-hour intervals. Two hours after the last injection, the rats were decapitated and adrenal capsular tissue was collected. Adrenomedullin had no effect on plasma and adrenal aldosterone concentrations in the rats fed a normal sodium diet. Rats fed a sodium-deficient diet had significantly increased aldosterone concentrations in both plasma (4770.1 +/- 364.3 pmol/L) and adrenal gland (57.34 +/- 3.27 pmol per adrenal). Subsequently, injection of adrenomedullin significantly inhibited increases in concentrations (plasma, 2648.9 +/- 313.2 pmol/L; adrenal, 44.28 +/- 4.94 pmol per adrenal). In nephrectomized rats, increased aldosterone concentrations in plasma and adrenal gland were also significantly inhibited by adrenomedullin. In the second part of the study, plasma renin concentration, adrenal renin activity, plasma corticosterone concentration, serum potassium concentration, and plasma immunoreactive adrenomedullin concentration were examined for adrenomedullin effects. The first four were unaffected, and the last, plasma immunoreactive adrenomedullin, was elevated 15% to 30%. These in vivo results, together with our in vitro data, suggest that adrenomedullin may indeed play a physiological role in the control of blood pressure and electrolyte balance.
Yamaguchi
T
T
Third Department of Medicine, Nagasaki (Japan) University, School of Medicine, Japan.
Baba
K
K
Doi
Y
Y
Yano
K
K
Kitamura
K
K
Eto
T
T
D053607:Adrenomedullin; D000450:Aldosterone / Q000096:biosynthesis* / Q000097:blood; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D003345:Corticosterone / Q000097:blood; D008297:Male; D009392:Nephrectomy; D010455:Peptides / Q000494:pharmacology*; D011188:Potassium / Q000097:blood; D051381:Rats; D017207:Rats, Sprague-Dawley; D012083:Renin / Q000097:blood; D012982:Sodium, Dietary / Q000008:administration & dosage; D015384:Zona Glomerulosa / Q000187:drug effects / Q000378:metabolism
D000959:Antihypertensive Agents; D010455:Peptides; D012982:Sodium, Dietary; D053607:Adrenomedullin; D000450:Aldosterone; D012083:Renin; D011188:Potassium; D003345:Corticosterone